Press Afssaps Following a warning from U.S. authorities (FDA) received 22 January 2009, Afssaps warns consumers about the risks of a slimming product called "Venom Hyperdrive 3.0", sold over the Internet. According to information provided by the FDA, it is manufactured in the USA and distributed in France. The product
"Venom Hyperdrive 3.0" is not authorized in France. It is not subject to any control by health authorities, and its marketing is illegal. It meets the definition of the drug due to its composition. In fact, according to analysis by the FDA, it contains a pharmacologically active substance, sibutramine, not indicated on the product packaging. This substance is an active ingredient contained in a medicinal product subject to medical prescription, requiring regular monitoring of patients because of the risk of adverse cardiovascular events. The product "Venom Hyperdrive 3.0" boasts an activity in weight loss and appetite control. According to the results of investigations by the FDA, this product is no longer manufactured but stocks are still existing.
health authorities are therefore cautioned consumers about the health risks of this product sold under the brand name "Venom Hyperdrive 3.0. It is strongly recommended not to eat, and advised people who have absorbed quickly consult their doctor for a checkup.
Sibutramine is present in the Sibutral ®, a drug approved in France since June 2001. Sibutral ® is indicated for weight loss in obese patients or overweight associated with other risk factors such as diabetes and / or high lipid levels. This medication is used in patients who have not lost enough weight after three months of diet and exercise physics. Taking sibutramine may be associated with adverse cardiovascular effects, including increased blood pressure and heart rate. This risk requires regular monitoring of the patient during treatment. The prescription of this drug is thus reserved to specialists and / or specialist services in endocrinology and metabolic diseases, cardiology, internal medicine. In addition, Afssaps especially forbidden incorporation of sibutramine in compounding in 2007.
Afssaps noted that in France the sale of drugs is only permitted in pharmacies, including the distribution network is controlled. It is therefore strongly recommended to buy drugs online.
"Venom Hyperdrive 3.0" is not authorized in France. It is not subject to any control by health authorities, and its marketing is illegal. It meets the definition of the drug due to its composition. In fact, according to analysis by the FDA, it contains a pharmacologically active substance, sibutramine, not indicated on the product packaging. This substance is an active ingredient contained in a medicinal product subject to medical prescription, requiring regular monitoring of patients because of the risk of adverse cardiovascular events. The product "Venom Hyperdrive 3.0" boasts an activity in weight loss and appetite control. According to the results of investigations by the FDA, this product is no longer manufactured but stocks are still existing.
health authorities are therefore cautioned consumers about the health risks of this product sold under the brand name "Venom Hyperdrive 3.0. It is strongly recommended not to eat, and advised people who have absorbed quickly consult their doctor for a checkup.
Sibutramine is present in the Sibutral ®, a drug approved in France since June 2001. Sibutral ® is indicated for weight loss in obese patients or overweight associated with other risk factors such as diabetes and / or high lipid levels. This medication is used in patients who have not lost enough weight after three months of diet and exercise physics. Taking sibutramine may be associated with adverse cardiovascular effects, including increased blood pressure and heart rate. This risk requires regular monitoring of the patient during treatment. The prescription of this drug is thus reserved to specialists and / or specialist services in endocrinology and metabolic diseases, cardiology, internal medicine. In addition, Afssaps especially forbidden incorporation of sibutramine in compounding in 2007.
Afssaps noted that in France the sale of drugs is only permitted in pharmacies, including the distribution network is controlled. It is therefore strongly recommended to buy drugs online.
Source
Afssaps
0 comments:
Post a Comment